Albiotic
General data
Product class:
Authorized package
Medicinal product class:
Veterinary medicine
Package code:
1147250
Name of medicinal product:
Albiotic
Active substances:
Lincomycin+Neomycin
Estonian
,
English
,
Latin
ATC code:
QJ51RF84
Dosage form:
intramammary solution
Route of administration:
intramammary use
Strengh:
330mg+100mg 10ml
Amount in package:
10ml 24TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Treatment of mastitis caused by micro-organisms susceptible to lincomycin and neomycin in lactating cows. Clinically relevant spectrum of activity: Staphylococcus species (both penicillinase and non-penicillinase producers) including Staphylococcus aureus, Streptococcus species including Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis, and coliform bacteria including Escherichia coli
Safety features:
No
Summary of product characteristics (SPC):
(last updated 29 May 2020)
Package information leaflet (PIL):
EST
(last updated 29 May 2020)
Labelling:
(last updated 29 May 2020)
Withdrawal time:
Lihale ja söödavatele kudedele: 3 päeva (72 tundi). Piimale: 3,5 päeva (84 tundi).
Species:
veis
Last imported to Estonia:
13 December 2023
Marketing authorization
Marketing authorization holder:
Huvepharma
Marketing authorization number:
1179
Marketing authorization issued on:
17 August 1998
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
National
Entry/Changing date: 24 August 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription